MedTrace Logo

An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry

NCT01892319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2446

Last updated 2019-11-19

No results posted yet for this study

Summary

This study is conducted in Europe and Asia. The purpose of the study (Diabetes Pregnancy Registry) is to evaluate the safety of treatment with insulin detemir in pregnant women with diabetes mellitus.

Conditions

Interventions

DRUG

insulin detemir

Patients will be treated according to routine clinical practice at the discretion of the treating physician

DRUG

other injectable antidiabetic treatment regimens

Patients will be treated according to routine clinical practice at the discretion of the treating physician

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Croatia
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Israel
  • Italy
  • Malaysia
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892319 on ClinicalTrials.gov